factor viii medication used treat prevent bleeding people hemophilia causes low factor certain preparations may also used von willebrands given slow injection side effects include skin flushing shortness breath fever red blood cell allergic reactions including anaphylaxis may unclear use pregnancy safe purified factor viii concentrate made human blood recombinant version also people may develop antibodies factor viii medication becomes less factor viii first identified became available medication recombinant factor viii first made approved medical use united states world health organizations list essential factor viii delivered intravenous transfer plasma byproduct blood stream hemophiliac often led transmission diseases hiv hepatitis purification methods improved early pharmaceutical companies began produce recombinant synthesized factor products prevent nearly forms disease transmission replacement therapycitation needed cost factor viii similar clotting factors described highly cost clotting factors medical costs people expensive gene therapy haemophilia might less expensive especially people severe